Quartel Adrian W
SEC insider (Form 3/4/5 filer). CIK 0001910132. Chief Medical Officer at SPRUCE BIOSCIENCES, INC. (SPRB) and 1 other issuer. 7 reported Form 4/5 transactions since Sep 2024; latest on Jul 27, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies Quartel Adrian W has filed insider reports for
- SPRUCE BIOSCIENCES, INC. (SPRB): Officer, Chief Medical Officer
- ZEVRA THERAPEUTICS, INC. (ZVRA): Officer, Chief Medical Officer
Quartel Adrian W
CIK: 0001910132
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Jul 27, 2026SPRB
SPRUCE BIOSCIENCES, INC.
AwardDirectRestricted Stock Units
13K shares- - Jan 30, 2026ZVRA
ZEVRA THERAPEUTICS, INC.
ExerciseDirect11.3K shares- - Jan 30, 2026ZVRA
ZEVRA THERAPEUTICS, INC.
SaleDirect4.5K shares at avg. $8.83$40K - Jan 29, 2026ZVRA
ZEVRA THERAPEUTICS, INC.
AwardDirectRestricted Stock Unit
37.5K shares- - Jan 29, 2026ZVRA
ZEVRA THERAPEUTICS, INC.
AwardDirectStock Option (right to buy)
75K shares- - Jan 30, 2025ZVRA
ZEVRA THERAPEUTICS, INC.
AwardDirectStock Option (right to buy)
68K shares- - Jan 30, 2025ZVRA
ZEVRA THERAPEUTICS, INC.
AwardDirectRestricted Stock Unit
34K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 27, 2026 |  SPRB SPRUCE BIOSCIENCES, INC. | Award Restricted Stock Units | 13,000 | - | - | Direct |
| Jan 30, 2026 |  ZVRA ZEVRA THERAPEUTICS, INC. | Exercise | 11,333 | - | $0 | Direct |
| Jan 30, 2026 | ZVRA ZEVRA THERAPEUTICS, INC. | Sale | 4,533 | $8.83 | $40,036 | Direct |
| Jan 29, 2026 | ZVRA ZEVRA THERAPEUTICS, INC. | Award Restricted Stock Unit | 37,500 | - | - | Direct |
| Jan 29, 2026 | ZVRA ZEVRA THERAPEUTICS, INC. | Award Stock Option (right to buy) | 75,000 | - | - | Direct |
| Jan 30, 2025 | ZVRA ZEVRA THERAPEUTICS, INC. | Award Stock Option (right to buy) | 68,000 | - | - | Direct |
| Jan 30, 2025 | ZVRA ZEVRA THERAPEUTICS, INC. | Award Restricted Stock Unit | 34,000 | - | - | Direct |
1-7 of 7 transactions